"The
Report Contraceptives Market to 2018 - Safety Concerns Plague
Drospirenone-containing Birth Control Pills and Long-term Use of
Estrogen provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GBI Research, a leading business
intelligence provider, has released its latest research,
“Contraceptives Market to 2018 Safety Concerns Plague
Drospirenone-containing Birth Control Pills and Long-term Use of
Estrogen”, which provides insights into the global contraceptives
market and market forecasts until 2018. The report provides an
in-depth analysis of the most commonly used contraceptives, such as
oral, topical, and injectable contraceptives, and devices such as
intrauterine devices, condoms, and vaginal rings. The report also
examines the usage patterns and annual cost of usage for these
segments. It also includes insights into the contraceptives R&D
product pipeline and explores the competitive landscape, including
major companies in the contraceptives market. Finally, the report
also includes analysis of the mergers and acquisitions (M&A) and
licensing agreements that have taken place in the global
contraceptives market.
The contraceptives market is
growing, and more than 90 million people from seven major markets
used them in 2011, with more than 24 million people having used them
in the US alone. The user population is expected to grow gradually
during the forecast period and reach more than 94 million in 2018.
View Report At
:http://www.marketresearchreports.biz/analysis/149605
According to GBI Research’s
analysis, in 2011, the contraceptives market was worth $10.2 billion,
indicating a Compounded Annual Growth Rate (CAGR) of 2.7% between
2004 and 2011. By 2018, the market is expected to reach $11.8
billion, growing at a CAGR of 2.1%. The launch of the FC patch,
AG200-15, Savvy Gel, LNG 20, Pill-Plus and some key products in the
late stage pipeline combined with increasing awareness are expected
to drive the market.
The annual cost of usage for
contraceptives was $113 in 2011, which grew from $104 in 2004 at a
CAGR of 1.2%. This is expected to grow to $125 in 2018, at a CAGR of
1.4% between 2011 and 2018. The growth rate can be attributed to
factors such as the expected patent expiry of Mirena and Yaz. In the
forecast period, CSD500, a condom manufactured by Futura Medical and
licensed to Reckitt and Benckiser, is expected to strengthen the
condom market.
The report is built using data and
information sourced from proprietary databases, primary and secondary
research, and in-house analysis by GBI Research’s team of industry
experts.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/149605
Scope
- Data and analysis on the contraceptives market in leading geographies: the US, the UK, Germany, France, Italy, Spain and Japan; along with their reach in emerging markets.
- Annualized market data for oral contraceptives, topical contraceptives, injectable contraceptives, condoms, intrauterine devices and vaginal rings in the contraceptives market from 2004–2011, with forecasts to 2018.
- Market data on the therapeutic landscape, which covers oral, topical and injectable contraceptives, and includes market revenues, treatment usage patterns and the annual cost of usage.
- Key drivers and restraints that have had a significant impact on the market.
- The competitive landscape of the contraceptives market, which includes companies such as Bayer, Merck, Church & Dwight, Warner Chilcott Company, and Pfizer.
- Key M&A activities and licensing agreements that took place from 2008–2012 in the contraceptives market.
Reasons to buy
- Align your product portfolio to markets with high growth potential.
- Develop market-entry and market expansion strategies by identifying the potential region and therapeutic segments poised for strong growth.
- Devise a more specifically-tailored country strategy through understanding of the key drivers and barriers in the contraceptives market of all the major countries.
- Develop key strategic initiatives by understanding the key focus areas of leading companies.
- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.
Table
of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9
2 Contraceptives Market to 2018 -
Introduction 10
3 Contraceptives Market to 2018 -
Market Overview 12
3.1 Introduction 12
3.2 Revenue Forecasts for
Contraceptives Market 12
3.2.1 Revenues 12
3.2.2 Annual Cost of Usage for
Contraceptives 15
3.2.3 Contraceptive Users 16
3.3 Drivers and Barriers for the
Contraceptives Market 17
3.3.1 Drivers for Contraceptives
Therapeutics Market 17
3.3.2 Barriers for Contraceptives
18
4 Contraceptives Market to 2018 -
Geographical Landscape 19
4.1 The US 19
4.1.1 Revenue 19
4.1.2 Annual Cost of Usage for
Contraceptives 20
4.1.3 Contraceptive Users 21
4.2 Top Five Countries of Europe
22
4.2.1 Revenue 22
4.2.2 Annual Cost of Usage for
Contraceptives 23
4.2.3 Contraceptive Users 24
4.3 Japan 25
4.3.1 Revenue 25
4.3.2 Annual Cost of Usage for
Contraceptives 26
4.3.3 Contraceptive Users 27
5 Contraceptives Market to 2018 -
Therapeutic Landscape 28
5.1 Oral Contraceptives 28
5.1.1 Introduction 28
5.1.2 Combined Hormonal
Contraception 29
5.1.3 Oral Contraceptive Historic
Trends 29
5.1.4 Recently Approved Combined
Oral Contraceptives 29
5.1.5 Revenue 30
5.1.6 Annual Cost of Usage 33
5.1.7 Oral Contraceptive Users 34
5.2 Injectables 35
5.2.1 Introduction 35
5.2.2 Revenue 35
5.2.3 Annual Cost of Usage 39
5.2.4 Injectable Contraceptive
Users 40
5.3 Topical Contraceptives 41
5.3.1 Introduction 41
5.3.2 Revenue 42
5.3.3 Annual Cost of Usage 45
Read
our latest Press Release
http://www.marketresearchreports.biz/pressreleases
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment